Biogen · Stock-Based Compensation

Latest reported$134.90Mperiod endingJun 30, 2026

BIIB Stock-Based Comp ($0.00 → $134.90M)

Annual stock-based compensation

High-resolution chart · PNG

BIIB stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	290,800,000
Dec 31, 2024	291,200,000
Dec 31, 2023	264,200,000
Dec 31, 2022	254,100,000
Dec 31, 2021	238,600,000
Dec 31, 2020	198,300,000
Dec 31, 2019	182,300,000
Dec 31, 2018	157,500,000
Dec 31, 2017	128,000,000
Dec 31, 2016	154,800,000
Dec 31, 2015	161,400,000
Dec 31, 2014	155,302,000
Dec 31, 2013	136,293,000
Dec 31, 2012	118,566,000
Dec 31, 2011	113,005,000
Dec 31, 2010	167,826,000
Dec 31, 2009	160,902,000
Dec 31, 2008	146,207,000
Dec 31, 2007	123,129,000
Dec 31, 2006	126,783,000
Dec 31, 2005	38,145,000
Dec 31, 2004	16,795,000
Dec 31, 2003	0
Dec 31, 2002	2,356,000
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0